Attached files

file filename
EX-32 - CERTIFICATION - LESCARDEN INCex_32.htm
EX-31 - CERTIFICATION - LESCARDEN INCex_31.htm
EXCEL - IDEA: XBRL DOCUMENT - LESCARDEN INCFinancial_Report.xls

 


 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
———————
FORM 10-Q
———————

þ
 QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
 
 ACT OF 1934
For the quarterly period ended: November 30, 2014
or
   
o
 TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
 
 ACT OF 1934
For the transition period from: _____________ to _____________

Commission File Number: 0-10035
 
———————
LESCARDEN, INC.
(Exact name of registrant as specified in its charter)
———————

New York
13-2538207
(State or other jurisdiction
(I.R.S. Employer
of incorporation or organization)
Identification No.)
 
420 Lexington Ave. Ste 212, New York 10170
(Address of Principal Executive Office) (Zip Code)
 
(212) 687-1050
(Registrant’s telephone number, including area code)
———————
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
 
þ
 Yes
o
 No
         
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).
 
o
 Yes
o
 No
 
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company.
   
Large accelerated filer
o    
Accelerated filer
   
Non-accelerated filer
o
 (Do not check if a smaller
 
Smaller reporting company
þ
 
   
 reporting company)
       
   
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
    o
 Yes
þ
 No
   
Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.
 
Class
 
Outstanding January 12, 2015
Common Stock $.001 par value
 
63,622,316
 
 



 
 
 
 
 
 
 
 
TABLE OF CONTENTS
Page
PART I – FINANCIAL INFORMATION
 
Item 1.         Financial Statements. 
3
Item 2.         Management’s Discussion and Analysis of Financial Condition and Results of Operations.                                                                                                                                             
                                                                                                                                                                                7
Item 3.         Quantitative and Qualitative Disclosures About Market Risk.    8
Item 4.         Controls and Procedures. 
  8
PART II – OTHER INFORMATION
Item 1.         Legal Proceedings. 
  9
Item 1A.      Risk Factors. 
  9
Item 2.         Unregistered Sales of Equity Securities and Use of Proceeds. 
9
Item 3.         Defaults Upon Senior Securities. 
  9
Item 4.         Submission of Matters to a Vote of Security Holders. 
  9
Item 5.         Other Information. 
  9
Item 6.         Exhibits. 
  9
SIGNATURES 
 

 

 
2

 

PART I - FINANCIAL INFORMATION

 
Item 1.         Financial Statements.
 
LESCARDEN INC.
CONDENSED BALANCE SHEETS
 

   
November 30,
2014
   
May 31,
2014
 
   
(UNAUDITED)
   
(AUDITED)
 
ASSETS
           
Current assets:
           
Cash and cash equivalents
  $ 8,251     $ 10,432  
Accounts receivable
    159,578       2,088  
Inventory
    88,248       113,572  
Total current assets
    256,077       126,092  
Deferred income tax asset, net of valuation allowance of $1,592,000 and $1,564,000 at November 30, 2014 and May 31, 2014 respectively
    ––       ––  
                 
Total assets
  $ 256,077     $ 126,092  
                 
LIABILITIES AND STOCKHOLDERS' DEFICIT
               
Current liabilities:
               
Accounts payable and accrued expenses
  $ 306,078     $ 220,592  
Shareholder loan
    129,000        
Deferred license fees
    1,500       4,500  
Total liabilities
    436,578       225,092  
                 
Stockholders' deficit
               
Convertible preferred stock - $.02 par value, authorized 2,000,000 shares, issued and outstanding 92,000 shares
    1,840       1,840  
Common stock - $.001 par value, authorized 200,000,000 shares, 63,622,316 issued and outstanding at November 30, 2014 and May 31, 2014
    63,622       63,622  
Additional paid-in capital
    17,505,936       17,505,936  
Accumulated deficit
    (17,751,899 )     (17,670,398 )
Stockholders' deficit
    (180,501 )     (99,000 )
Total liabilities and stockholders' deficit
  $ 256,077     $ 126,092  

See notes to financial statements
 
 
 
3

 

 
LESCARDEN INC.
CONDENSED STATEMENTS OF OPERATIONS (UNAUDITED)
 

   
For the three months
Ended November 30,
   
For the six months
Ended November 30,
 
   
2014
   
2013
   
2014
   
2013
 
Revenues:
                       
Product sales
  $ 165,023     $ 9,836     $ 171,270     $ 317,927  
License fees
    1,500       1,500       3,000       3,000  
Total revenues
    166,523       11,336       174,270       320,927  
                                 
Costs and expenses:
                               
Cost of sales
    42,078       2,296       43,309       136,597  
Salaries
    13,838       27,916       41,099       57,086  
Professional fees and consulting
    24,297       19,597       60,209       49,241  
Rent and office expense
    31,187       28,502       62,400       58,650  
Insurance
    12,933       17,767       24,801       30,626  
Commission
    10,743             10,743       20,689  
Other administrative expenses
    12,464       4,693       13,210       10,108  
Total costs and expenses
    147,540       100,771       255,771       362,997  
                                 
Net income (loss)
  $ 18,983     $ (89,435 )   $ (81,501 )   $ (42,070 )
                                 
Net income (loss) per share – basic and diluted
  $ 0.00     $ (0.00 )   $ (0.00 )   $ (0.00 )
                                 
Weighted average number of common
shares outstanding – basic and diluted
    63,622,316       48,722,316       63,622,316       48,722,316  

See notes to financial statements
 
 
 
4

 
 
LESCARDEN INC.
CONDENSED STATEMENTS OF CASH FLOWS (UNAUDITED)

   
For the six months
Ended November 30,
 
   
2014
   
2013
 
             
Cash flows from operating activities:
           
Net loss
  $ (81,501 )   $ (42,070 )
Adjustments to reconcile net loss to net cash
used in operating activities:
               
Changes in operating assets and liabilities
               
(Increase) decrease in accounts receivable
    (157,490 )     25,266  
Decrease in inventory
    25,324       12,272  
Increase (decrease) in accounts payable and accrued expenses
    85,486       (53,297 )
Decrease in deferred revenue
          (4,782 )
Decrease in deferred license fees
    (3,000 )     (3,000 )
Net cash used in operating activities
    (131,181 )     (65,611 )
                 
Cash flows from investing activities:
    -       -  
                 
Cash flows from financing activities:
               
Proceeds from shareholder loan
    129,000       100,000  
Cash provided by financing activities
    129,000       100,000  
                 
                 
(Decrease) increase in cash
    (2,181 )     34,389  
                 
Cash - beginning of period
    10,432       84,562  
                 
Cash – end of period
  $ 8,251     $ 118,951  
                 
Supplemental Disclosures of Cash Flow Information                
 Cash paid for interest  
$
   
$
 
 Cash paid for taxes  
$
380    
$
380   

 
See notes to financial statements
 

 
5

 
 
 
LESCARDEN INC .
(UNAUDITED) NOTES TO FINANCIAL STATEMENTS
 
November 30, 2014
 
Note 1 - General:
 
The accompanying condensed financial statements include all adjustments that are, in the opinion of management, necessary for a fair statement of the results for the interim periods. All such adjustments are of a normal recurring nature. The statements have been prepared in accordance with the requirements for Form 10-Q and, therefore, do not include all disclosures or financial details required by generally accepted accounting principles. These condensed financial statements should be read in conjunction with the financial statements and the notes thereto included in the Company's Annual Report on Form 10-K for the year ended May 31, 2014. The results of operations for the interim periods are not necessarily indicative of results to be expected for a full year's operations.
 
Note 2 – Going Concern:
 
The accompanying financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The financial statements do not include any adjustments relating to the recoverability of assets and the satisfaction of liabilities that might be necessary should the Company be unable to continue as a going concern. As shown in the financial statements, the Company incurred a loss from operations for the six months ended November 30, 2014 of $81,501, has a stockholders’ deficiency of  $180,501 and a working capital deficiency of  $180,501. These conditions raise substantial doubt about the Company’s ability to continue as a going concern.
 
The Company’s plan and ability to continue as a going concern is primarily dependent upon its ability to maintain consistent production volumes to fulfill existing sales orders.  Alternative sources of supply are being evaluated so that manufacturing and production disruptions can be minimized. There can be no assurance that the Company will be able to establish an alternative source of supply and maintain consistent production volumes to meet demand.  The establishment of an alternative source of supply may require additional future expenditures given the uncertainties associated with the regulatory, logistic and financial issues involved but it is likely that testing and regulatory certification will necessitate at least three months before production commences.
 
Note 3 – Inventory:
 
At November 30, 2014, inventory of $88,248 consisted of $36,362 of finished goods and $51,886 of raw materials.
 
Note 4 – Related Party Transactions:
 
In August 2014, the Company received additional unsecured loans aggregating $129,000 from its Chairman. The loans are interest bearing and due upon demand.  Pursuant to an agreement with a director of the Company, sales commission expense of $10,743 for services rendered in connection with the sale of Citrix in Europe was accrued during the three months ended November 30, 2014.
 
Note 5- Commitments and Contingencies:

At November 30, 2014, the Company is obligated under a non-cancellable lease with an unrelated third party to rent office space which expires on January 31, 2016.  The Company is currently negotiating a termination of this lease.  At November 30, 2014, the Company has minimum future rental payments due on this lease of $105,161.

There have been no other significant subsequent developments relating to the commitments and contingencies reported on the Company’s latest Annual Report on Form 10-K.
 
 
 
6

 


 
Item 2.         Management’s Discussion and Analysis of Financial Condition and Results of Operations.
 
Results of Operations:
 
The results of operations for the three and six months ended November 30, 2014 reflect ongoing production disruptions, which has delayed fulfillment of purchase orders to European markets.  Preliminary estimates from alternative suppliers of raw material supply indicate significant increases in the unit cost of raw material and there is ongoing uncertainty as to the timing of production capability and fulfillment of outstanding purchase orders.
 
Three months ended November 30, 2014 compared to November 30, 2013
 
The Company’s revenues increased in the fiscal quarter ended November 30, 2014 by $155,187 due to the production shipment of Catrix in November 2014.  Cost of sales as a percent of sales was 25% for the three months ended November 30, 2014 reflecting lower raw material costs of discounted raw material purchases.
 
Non-direct costs and expenses during the three months ended November 30, 2014 were 7% higher than those of the comparative prior-year period due to increases in professional fees and commissions of $4,700 and $10,743 offset by decreased salaries and insurance of $14,078 and $4,834 respectively.
 
Six months ended November 30, 2014 compared to November 30, 2013
 
The Company’s revenues decreased in the six months ended November 30, 2014 compared to November 30, 2013 by 46% or $146,657 due to the Company’s inability to reestablish production operations. Cost of sales as a percent of sales decreased from 43% for the six months ended November 30, 2013 to 25% reflecting the one-time acquisition of discounted raw material that decreased raw material cost.
 
Non-direct costs and expenses during the six months ended August 31, 2014 were 6% lower than those of the comparative prior-year period.
 
Liquidity and Capital Resources
 
As of November 30, 2014, the Company’s liabilities exceeded its assets by $180,501. The Company’s cash and cash equivalents balance decreased by $2,181 in the six months ended November 30, 2014 to $8,251.
 
The Company has no material commitments for capital expenditures at November 30, 2014.
 
 
 
7

 
 
 
Item 3.         Quantitative and Qualitative Disclosures About Market Risk.
 
Not required for smaller reporting company.
 
 
Item 4.         Controls and Procedures.
 
The Company maintains disclosure controls and procedures that are designed to ensure that information required to be disclosed in the Company’s filings under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the periods specified in the rules and forms of the Securities and Exchange Commission. Such information is accumulated and communicated to the Company’s management, including its Chief Executive and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure. The Company’s management, including the Chief Executive and Chief Financial Officer, recognizes that any set of controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives.
 
The Company has carried out an evaluation, under the supervision and with the participation of the Company’s management, including the Company’s Chief Executive and Chief Financial Officer, of the effectiveness of the design and operation of the Company’s disclosure controls and procedures. Based on such evaluation, the Company’s Chief Executive and Chief Financial Officer concluded that the Company’s disclosure controls and procedures are effective as of the end of the period covered by this quarterly report on Form 10-Q.
 
There have been no significant changes in the Company’s internal controls or in other factors that could significantly affect the internal controls subsequent to the date of their evaluation in connection with the preparation of this quarterly report on Form 10-Q.
 
 
 
8

 
 

PART II - OTHER INFORMATION
 

 
 
Item 1.         Legal Proceedings.
 
None.
 
 
Item 1A.      Risk Factors.
 
None.
 
 
Item 2.         Unregistered Sales of Equity Securities and Use of Proceeds.
 
None
 
 
Item 3.         Defaults Upon Senior Securities.
 
None.
 
 
Item 4.         Submission of Matters to a Vote of Security Holders.
 
None.
 
 
Item 5.         Other Information.
 
None.
 
 
Item 6.         Exhibits.
 
Exhibit No.
     
Description
 
Certification pursuant to Exchange Act Rule 13a – 14 (a)/15d-14(a)
 
Certification pursuant to 18 U.S.C. Section 1350 as adopted pursuant to section 906 of the Sarbanes-Oxley Act of 2002

 
 
9

 

 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 
 
LESCARDEN INC.
 
 
(Registrant)
 
       
Date: January 12, 2015
By:
/s/ William E. Luther  
   
William E. Luther
 
    Chief Executive and Chief Financial Officer